What You Should Know:
– Global medical technology company Smith+Nephew has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems to the U.S. Department of Defense (DoD).
– The single-award contract, facilitated through the Defense Logistics Agency (DLA), spans 10 years and is valued at up to $75M.
– The agreement will equip military medical providers with an advanced solution for managing complex wounds across various stages of care, from prolonged casualty situations to definitive treatment in military facilities
Advanced Wound Care Tailored for Military Needs
The RENASYS TOUCH NPWT System has demonstrated clinical efficacy and operational fitness, crucial for demanding military environments. Key features include its portability, an intuitive user interface, and the capacity to deliver a range of therapy modes, set points, and cycle times, allowing for individualized patient care. The system, manufactured in the United States, is designed to support military medical personnel in administering therapy through prolonged casualty care, first surgical intervention, aeromedical transport, and definitive care in military treatment facilities
“Future conflicts will be more difficult and complex. This implies medical devices and treatments will need to be simplified and more intuitive to be used farther forward by a wide range of providers,” said Dennis Lyons, MSG (ret), SO-ATP and Sr. Director Military & Federal Health for Smith+Nephew. “RENASYS TOUCH NPWT will provide that simplified negative pressure wound therapy solution to the military care continuum for warfighters who need it most”.
